Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

The Effect of Hachimi-Jio-Gan (Ba-Wei-Di-Huang-Wan) on the Quality of Life in Patients with Peripheral Arterial Disease - A Prospective Study Using Kampo Medicine.

Kawago K, Shindo S, Inoue H, Akasaka J, Motohashi S, Urabe G, Sato M, Uchiyama H, Ogino H.

Ann Vasc Dis. 2016;9(4):289-294. doi: 10.3400/avd.oa.15-00133. Epub 2016 Sep 15.

2.

Validation of a Brazilian Portuguese Version of the Walking Estimated-Limitation Calculated by History (WELCH).

Cucato GG, Correia Mde A, Farah BQ, Saes GF, Lima AH, Ritti-Dias RM, Wolosker N.

Arq Bras Cardiol. 2016 Jan;106(1):49-55. doi: 10.5935/abc.20160004. Epub 2015 Dec 8. English, Portuguese.

3.

Predictors of walking capacity in peripheral arterial disease patients.

Farah BQ, Souza Barbosa JP, Cucato GG, Chehuen Mda R, Gobbo LA, Wolosker N, Forjaz CL, Ritti-Dias RM.

Clinics (Sao Paulo). 2013 Apr;68(4):537-41. doi: 10.6061/clinics/2013(04)16.

4.

Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status.

Nead KT, Zhou M, Diaz Caceres R, Olin JW, Cooke JP, Leeper NJ.

Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):255-61. doi: 10.1161/CIRCOUTCOMES.111.000070. Epub 2013 Apr 30.

5.
6.

Further clinical validation of the walking impairment questionnaire for classification of walking performance in patients with peripheral artery disease.

Sagar SP, Brown PM, Zelt DT, Pickett WL, Tranmer JE.

Int J Vasc Med. 2012;2012:190641. doi: 10.1155/2012/190641. Epub 2012 Aug 2.

7.

The effects of smoking status on walking ability and health-related quality of life in patients with peripheral arterial disease.

Fritschi C, Collins EG, O'Connell S, McBurney C, Butler J, Edwards L.

J Cardiovasc Nurs. 2013 Jul-Aug;28(4):380-6. doi: 10.1097/JCN.0b013e31824af587.

8.

Assessment of functional status and quality of life in claudication.

Mays RJ, Casserly IP, Kohrt WM, Ho PM, Hiatt WR, Nehler MR, Regensteiner JG.

J Vasc Surg. 2011 May;53(5):1410-21. doi: 10.1016/j.jvs.2010.11.092. Epub 2011 Feb 18. Review.

9.

Abnormal joint powers before and after the onset of claudication symptoms.

Koutakis P, Johanning JM, Haynatzki GR, Myers SA, Stergiou N, Longo GM, Pipinos II.

J Vasc Surg. 2010 Aug;52(2):340-7. doi: 10.1016/j.jvs.2010.03.005.

10.

The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients.

Huisinga JM, Pipinos II, Johanning JM, Stergiou N.

J Neuroeng Rehabil. 2010 Jun 7;7:25. doi: 10.1186/1743-0003-7-25.

11.

Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication.

Kruidenier LM, Nicolaï SP, Willigendael EM, de Bie RA, Prins MH, Teijink JA.

BMC Cardiovasc Disord. 2009 Mar 2;9:9. doi: 10.1186/1471-2261-9-9.

Supplemental Content

Support Center